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Background: There has been increasing recognition of the detrimental effect of peripheral arterial disease (PAD) on the
health of Americans, and yet there is no common national program of public PAD education designed to diminish this
effect.
Format: To heighten awareness of this problem, a 2-day PAD Public Education Strategy Meeting was recently attended
by representatives of 17 professional societies and public health associations whose missions support the prevention,
diagnosis, treatment, and rehabilitation of vascular diseases. This Public Education Strategy Meeting was intended to
provide the rationale and structure to create a national PAD public awareness campaign to diminish the health effect of
PAD and to improve cardiovascular outcomes in the United States. This document (1) provides the rationale for creation
of a national PAD public education program; (2) reviews the development and success of national hypertension,
hypercholesterolemia, and Women’s Heart Health public education programs as models of educational efficacy; (3)
elucidates how the work of many vascular professionals has led to a national consensus for creation of a national PAD
public educational program; (4) provides an overview of the National Heart, Lung, and Blood Institute PAD education
meeting; and (5) outlines the “next steps” required to accomplish these goals.
Outcome: This meeting achieved consensus that we share responsibility for developing accurate, unified messages to
promote PAD awareness and improved care. Participants agreed that the creation of such messages should be linked to
plans to disseminate them to all Americans at risk. A consensus was reached that such messages, when commonly created
and offered to the public, are most likely to achieve the rewards in better health that all Americans deserve. The Vascular
Disease Foundation, a not-for-profit foundation whose mission includes public education about the prevention,
diagnosis, treatment, and rehabilitation of PAD, will devote its resources to guide a new coalition in this process and to
create a national PAD awareness campaign. During 2003 and 2004, the coalition will create the organizational
underpinnings and time line for what will undoubtedly be a multiyear effort.
Conclusion: Participants of the Public Education Strategy Meeting agreed to create a broad coalition to develop a National
PAD Public Awareness Program, with the objectives to develop and disseminate public education massages on PAD. A
successful national PAD education program will contribute to creation of a broader mandate to improve global
cardiovascular health in the United States. (J Vasc Surg 2004;39:474-81.)
Over the past decade, there has been increasing
recognition of the major detrimental effect of peripheral
arterial disease (PAD) on the health of Americans. To
heighten awareness of this problem, a 2-day PAD Public
Education Strategy Meeting was held in Bethesda, Md,
on January 15-16, 2003. The meeting was coordinated
by the Vascular Disease Foundation (VDF) and hosted
by the National Heart, Lung, and Blood Institute
(NHLBI) of the National Institutes of Health. In addi-
tion to the NHLBI, it was also attended by representa-
tives of 16 professional societies and public health asso-
ciations whose missions support the prevention,
diagnosis, treatment, and rehabilitation of vascular dis-
eases (Appendix 1, online only). This Public Education
Strategy Meeting was intended to provide the rationale
and structure to create a national PAD public awareness
campaign to diminish the public health effect of PAD
and to improve cardiovascular outcomes in the United
States.
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RATIONALE FOR NATIONAL
CARDIOVASCULAR PUBLIC EDUCATION
PROGRAMS
National public awareness campaigns have successfully
contributed to the prevention, early detection, and treat-
ment of many disease states. These educational programs
have typically focused on major public health problems
such as breast cancer, acquired immunodeficiency syn-
drome (AIDS), and cardiovascular disease. These cam-
paigns have often been created by the synergy that is
achieved by the combination of public sector advocacy (eg,
not-for-profit foundations) and governmental program
support.
A number of successful national public educational
programs have been developed to diminish both risk factors
and manifestations of cardiovascular disease, in recognition
that cardiovascular illnesses are the leading cause of death in
the United States. Peripheral arterial disease is one of the
three major clinical atherosclerotic syndromes, and its
pathogenesis is a consequence of common risk factors, such
as diabetes, tobacco smoking, hypertension, and hypercho-
lesterolemia. Moreover, as a major manifestation of cardio-
vascular disease, it is a potent predictor of myocardial
infarction, stroke, and death. Thus, it is logical for PAD to
now be an additional target of current and future national
educational programs.
The NHLBI now supports five such programs: the
National High Blood Pressure Education Program, the
National Cholesterol Education Program, the National
Heart Attack Alert Program, the Obesity Education Initia-
tive, and the Women’s Heart Health Education Initiative.
From these initiatives, the American public has achieved
real benefit. As a result of these programs, individuals now
know about the importance of (1) measuring and lowering
their blood pressure; (2) measuring and lowering their
blood cholesterol; (3) the symptoms of heart attack, allow-
ing more prompt treatment and effective resuscitation from
cardiac arrest; (4) the risks of obesity and of a sedentary
lifestyle, as well as the benefits of achieving an ideal body
weight; and (5) for women, their personal risk of cardio-
vascular disease and its symptoms.
This document is designed to (1) provide the rationale
for creation of a national PAD public education program,
(2) review the development and success of national hyper-
tension and hypercholesterolemia public education pro-
grams as models of educational efficacy, (3) elucidate how
the work of many vascular professionals has led to a national
consensus for creation of a national PAD public educational
program, (4) provide an overview of the NHLBI PAD
education meeting, and (5) outline the “next steps” re-
quired to accomplish these goals.
RATIONALE FOR CREATION OF A PAD
PUBLIC EDUCATION PROGRAM
PAD is a highly prevalent disease, affecting 8 to 10
million Americans and between 12% and 20% of older
adults.1-3 Individuals with PAD suffer a markedly increased
risk of cardiovascular ischemic events that is increased 7- to
10-fold and a short-term mortality that is increased at least
3-fold compared with an age-matched cohort.4-10 PAD is
associated with a major detrimental affect on quality of
life.11-17 Individuals with “asymptomatic” PAD (defined
by an ankle-branchial index [ABI] less than 0.9, but the
absence of classic claudication) are functionally impaired, as
recent data now demonstrate that such individuals suffer a
slower walking velocity, poorer standing balance score, and
walk fewer blocks per week than comparable individuals
without PAD, even after adjustment for age, gender, risk
factors, and other comorbidities.11,18-21 Overall, current
data document that asymptomatic PAD is common and is
independently associated with impaired lower-extremity
functioning. Individuals with claudication suffer a markedly
diminished functional status and quality of life. Severe PAD
and its end-stage clinical manifestation, critical limb isch-
emia, is present in approximately 500 individuals per mil-
lion; between 10% and 30% of patients with critical limb
ischemia will suffer a major nonfatal or fatal cardiovascular
event over 6 to 12 months after diagnosis; and less than half
of patients with critical limb ischemia survive without a
major amputation 6 months after presentation.22 Thus, the
high prevalence, functional consequences, cardiovascular
ischemic risk, risk of amputation, and associated mortality
of PAD place a considerable burden on individuals and on
all American communities and consume national health
care resources.
Americans at risk of PAD or those who have undiag-
nosed PAD could best be served by prompt diagnosis.23
The fraction of individuals at risk who have had an ankle-
brachial index measurement, the fraction of individuals
with PAD who are being treated with secondary prevention
strategies to reduce cardiovascular risk, the fraction with
critical limb ischemia who undergo revascularization, and
the fraction who have suffered a PAD-related amputation
could easily be ascertained. These data are currently not
known, and the absence of these data impedes measure-
ment of the efficacy of both clinician and public interven-
tions to improve PAD-associated outcomes. The success of
any national PAD awareness campaign would require the
application of continuing outcomes assessments to demon-
strate the ongoing programmatic value, as has been accom-
plished in the programs cited earlier. The survey mecha-
nism used in National Health and Nutrition Examination
Survey (NHANES) could encompass these additional mea-
sures of global atherosclerosis, as they are known to con-
tribute to global cardiovascular health.
A clear public understanding that PAD is one of the
strongest markers of cardiovascular risk is critical. Few
Americans are now evaluated to determine the presence of
PAD, awareness of the diagnosis is low, and the benefits of
treatment are not well appreciated.23-25 Individual clini-
cians and individual professional societies have successfully
promoted the valuable role of the ankle-brachial index
measurement to provide accurate PAD detection (Table I).
Current data demonstrate that PAD diagnostic and thera-
peutic interventions can decrease cardiovascular ischemic
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event rates, improve quality of life, and prevent amputa-
tion.22,26-29 Pharmacological interventions, exercise, en-
dovascular techniques, and surgical treatments, used indi-
vidually or together, are known to improve clinical
outcomes of individuals with PAD. Despite these advances,
these data remain poorly understood by the public. With-
out a unified program of national PAD education, these
data will remain obscure to the public, the expected public
health gains will not be realized, and the benefits of our
investment in vascular research will not be translated into
better health.
EVIDENCE THAT PUBLIC EDUCATION LEADS
TO “REAL WORLD” HEALTH BENEFITS
An effective national public education program must be
both well conceived to meet a health-related educational
need and designed to achieve measurable outcomes. To
this end, as we consider the prospects of creating a national
PAD public awareness campaign, there is value in assessing
how educational goals have previously been accomplished.
Central to all of these efforts has been the creation of broad
coalitions of public organizations and federal agencies that
work collaboratively to create a large, public-focused, data-
driven message. Two examples of the diversity of these
coalitions are offered in Appendix 2, online only.
Prior to the establishment of a hypertension awareness
initiative, few Americans were aware that high blood pres-
sure represents a marker of cardiovascular risk. At the same
time, the importance of blood pressure monitoring and
treatment of hypertension was not embraced by the medi-
cal establishment. Although individual clinicians and some
organizations promoted the value of regular blood pressure
measurements, and although prospective randomized trials
demonstrated that blood pressure–lowering interventions
decreased rates of myocardial infarction, stroke, heart fail-
ure, end-stage renal disease, and death, these data remained
poorly understood by the public until the development of a
national program of high blood pressure education. The
National High Blood Pressure Education Program (NHB-
PEP) was established in 1972 by the National Heart, Lung,
and Blood Institute. The NHBPEP, as a coalition of 39
major professional, public, and voluntary organizations and
7 federal agencies, has both developed a model for national
hypertension education and demonstrated that this pro-
gram has increased public awareness, prevention, treat-
ment, and control of hypertension. Awareness and treat-
ment of high blood pressure have been sequentially
assessed as a component of NHANES. From the 1976-
1980 survey (NHANES II) to the 1988-1994 survey
(NHANES III), the percentage of Americans who were
Table I. Past peripheral arterial disease public education and screening programs
Program Sponsor Date Goals of program
Step Lively Hoechst Marion
Roussel
Pharmaceuticals
1988-1990 Community-based PAD detection
by use of the ABI
A Step Ahead Society for Vascular
Nursing
1990-1996 Community-based PAD detection
by use of the ABI, educational
intervention
Minnesota Peripheral
Arterial Disease
Screening Program
University of Minnesota 1996-1997 Assessment of efficacy of
community PAD detection; risk
factor profile assessment;
treatment intensity; patient
PAD awareness
Legs For Life Society for
Interventional
Radiology
1998-present Raise public awareness and
provide screening for PAD,
carotid disease, and AAA
PARTNERS Program
(Peripheral Arterial
Disease Awareness,
Risk, and Treatment:
New Resources for
Survival)
Academic Steering
Committee; Bristol
Myers-Squibb/
Sanofi-Synthelabo
Partnership
1999 data collection;
publication in
2001.
Assessment of efficacy of
community PAD detection; risk
factor profile assessment;
treatment intensity; patient and
clinician PAD awareness;
prospective cross-sectional
survey of PAD vs other CV
disease prevalence in primary
care practice; educational
intervention 25
Save A Leg, Save a Life Vascular Disease
Foundation
1999-present Web, brochure, and newsletter-
based patient educational
campaign
American Vascular
Association Screening
Program
Society for Vascular
Surgery and
American Association
for Vascular Surgery
2001-present Community-based PAD, AAA,
and carotid disease detection by
use of the ABI, abdominal
ultrasound, and carotid duplex
methods; educational
intervention
PAD, Peripheral arterial disease; ABI, ankle-brachial index; AAA, abdominal aortic aneurysm; CV, cardiovascular.
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aware that they had high blood pressure increased from
51% to 73%.30 Among persons with hypertension, the
fraction of hypertensive individuals who receive treatment
also increased from 31% to 55% during that same period. As
a final measure of program efficacy, NHANES demon-
strated that the fraction of persons with high blood pressure
who achieve control to below the 140/90 mmHg target
has increased from 10% to 29% from NHANES I to III,
confirming the relevance of public education about hyper-
tension. The national program to improve the detection
and treatment of hypertension was linked to the publica-
tion of peer-reviewed national treatment guidelines.31 Ed-
ucation of the public, linked to education of clinicians, can
result in real-world health gains.
Likewise, public awareness of the risks of hypercholes-
terolemia was low prior to a major public awareness effort.
Serum lipid levels were not routinely obtained, and the
benefits of treatment were not well appreciated. Although
individual clinicians and some organizations promoted the
valuable role of lipid assessments, and although prospective
randomized trials demonstrated that cholesterol-lowering
interventions decreased cardiovascular ischemic event rates,
these data remained poorly understood by the public until
the development of a national program of cholesterol edu-
cation. The National Cholesterol Education Program
(NCEP) was initiated by the NHLBI in November 1985.
The goal of the NCEP is to reduce illness and death from
coronary heart disease in the United States by reducing the
fraction of Americans with high blood cholesterol. The
NCEP is designed to provide educational efforts directed at
both the public and health professionals. Programmatic
success has been defined in a series of steps, including the
publication of treatment guidelines, such as the most recent
report from the NCEP-Adult Treatment Panel III (ATP
III) and the promotion of these guidelines, related materi-
als, and tools to both patients at risk and to clinicians in
practice.32 The Cholesterol Awareness Survey of physicians
and the public has provided evidence that the percentage of
the public who has had their blood cholesterol determined
increased from 35% to 75% from 1983 to 1995. Translated
to the population at risk, the NCEP has, therefore, helped
approximately 70 to 80 million Americans who, once un-
aware of their blood cholesterol level, have now the basis on
which to take action to reduce their cardiovascular risk. In
1995, physicians reported initiating diet and drug treat-
ment at much lower cholesterol levels than in 1983, and
office-based care for hypercholesterolemia more closely
approximates NCEP recommendations. The efforts of the
NCEP and Coordinating Committee member organiza-
tions have led to significant improvements in professional
and public attitudes, knowledge, and practices about high
blood cholesterol and heart disease. The Third National
Health and Nutrition Examination Survey (NHANES III)
(1988-1994) also demonstrates that the public’s intake of
saturated fat and total fat has declined and that blood
cholesterol levels have dropped. Since 1978, average total
cholesterol levels among US adults have fallen from 213
mg/dL to 203 mg/dL, and the prevalence of cholesterol of
240 mg/dL or higher has declined from 26% to 19%.
Moreover, coronary heart disease mortality has continued
to decline. Taken together, these progress indicators dem-
onstrate that public cholesterol education has had a signif-
icant effect. It is known that this effect was directly related
to the clinician and public educational interventions from
data collected during regional efficacy evaluations of both
the Minnesota Heart Survey and the Stanford University–
managed Five City Project.33-36
INITIAL STEPS ON THE ROAD TO SUCCESS-
BUILDING CONSENSUS
The Vascular Disease Foundation (VDF) was created in
1998 to serve as a not-for-profit, public-focused organiza-
tion to create and disseminate educational information on
vascular diseases (www.vdf.org). In less than 5 years, the
VDF has grown from a regional PAD-focused public edu-
cational association into an interdisciplinary national orga-
nization devoted to supporting all aspects of vascular public
education. To assure the creation of science-based, credi-
ble, and easy-to-understand vascular information, material
is written and reviewed by a multidisciplinary committee of
vascular health professionals and public members. Primary
avenues for information dissemination are by way of
printed brochures, public newsletter, attendance at health
conventions and other community health programs, and
web site that provide relevant information on the broad
scope of vascular diseases. The VDF currently includes both
members of the public and representatives of eight major
vascular professional societies, including the American As-
sociation of Cardiovascular and Pulmonary Rehabilitation,
American College of Cardiology, Society for Clinical Vas-
cular Surgery, Society for Vascular Medicine and Biology,
Society of Interventional Radiology, Society for Vascular
Nursing, Society for Vascular Surgery, and Society for
Vascular Ultrasound. The professional societies repre-
sented within the VDF now include more than 40,000
American health professionals; this represents a powerful
coalition. In the development of its strategic plan to pro-
vide broad vascular education, the VDF considered that the
cardiovascular effect of PAD would serve as the most im-
portant critical educational initiative. Achievement of this
goal was proposed to be best accomplished in the context
of the congressionally mandated Healthy People 2010 initia-
tive.
Healthy People 2010 is a set of specific health objectives
for the United States population to achieve over the first
decade of the new century (www.healthypeople.gov). The
first goal of Healthy People 2010 is to help individuals of all
ages increase life expectancy and improve their quality of
life. The second goal of Healthy People 2010 is to eliminate
health disparities among different segments of the popula-
tion. Inasmuch as PAD is prevalent, is associated with a
high mortality, and decreases quality of life, a public edu-
cational focus on PAD directly supports the first goal of
Healthy People 2010. PAD is underdiagnosed and under-
treated in most American populations, whether urban or
rural, affecting both genders and all ethnicities; a national
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PAD public health campaign, therefore, should aid achieve-
ment of the second goal of Healthy People 2010. A health
disparity exists if education about cardiovascular risk reduc-
tion is promoted to those with clinically evident coronary
heart disease but not to those with PAD who are at equal
cardiovascular risk. Within this framework, the VDF re-
quested an opportunity to collaborate with the NHLBI to
consider steps that would best lead to improved public
access to accurate information about PAD. These discus-
sions by the VDF and NHLBI were held between 2000 and
2001 and led to creation of the 2003 PAD Public Educa-
tion Strategy Meeting.
Over the past 2 years, growing interest in PAD and its
public health effect generated an additional series of scien-
tific and educational symposia that contributed to the cur-
rent momentum. In July 2002, the American Heart Asso-
ciation created an “Atherosclerotic Vascular Disease
Summit” to review trends in the epidemiology, pathophys-
iology, diagnosis, and treatment of atherosclerotic periph-
eral arterial disease. This meeting successfully expanded
interest in both public and research-directed initiatives. In
August 2002, a “Peripheral Vascular Health Summit,”
hosted by the Society of Interventional Radiology, was
attended by those vascular professional organizations with
an interest in PAD. This forum explored ways in which
these organizations could work collaboratively to further
their common goals. A topic addressed at the summit was
the need for a broad-based multispecialty organization to
serve as the nucleus of a vascular coalition. One of the
resolutions reached was that the Vascular Disease Founda-
tion could expand its current role and serve as the coalition
organization under which common goals and objectives
could be furthered. In addressing the summit participants,
Dr. Eve Slater, assistant secretary of the Department of
Health and Human Services, urged the group to speak with
a single voice and to develop a unified message to success-
fully move forward.
The 2003 NHLBI workshop portion of the Public
Education Strategy Meeting was, therefore, designed to
support the Vascular Disease Foundation and its partners in
taking the next step toward raising public awareness about
vascular diseases in general and, more specifically, periph-
eral arterial disease.
THE PAD PUBLIC EDUCATION STRATEGY
MEETING: CONSENSUS AT HAND
At the NHLBI Workshop on Developing a Public
Awareness Campaign, Dr. Claude Lenfant, director of the
NHLBI, outlined the need for public health messages to be
anchored in a robust scientific evidence base. In addition, a
national cardiovascular public educational program must
devise messages that are inclusive of the needs of all seg-
ments of the public and should use methods known to
reach the public at risk of PAD. The development of such
messages to be used in any program of national scope
requires the input of all vascular professionals, public advo-
cacy groups, as well as organizations with expertise in
communications and public relations. The need to main-
tain stepwise consensus in such a process was outlined by
reviewing the creation of the successful “Heart Truth Cam-
paign” (www.nhlbi.nih.gov/health/heartruth). The Heart
Truth Campaign was created to increase the appreciation
that in women, as in men, the leading cause of death is heart
disease. The campaign’s goal is to give women a personal
and urgent “wake-up call” about their risk of heart disease.
This campaign was based on the findings from the NHLBI
Women’s Heart Health Education Strategy Development
Workshop held in March 2001, with the advocacy of orga-
nizations allying with Womenheart: The National Coali-
tion for Women with Heart Disease (www.women
heart.org). More information is available from the
resources listed in Appendix 3.
The role of the VDF, whose public and professional
interdisciplinary structure provides a role for all national
stakeholders, permitted the creation of a broad national
vascular public educational coalition that led to the PAD
Public Education Strategy Meeting. It was acknowledged
that all of the vascular professional societies have consider-
able expertise in the evaluation, treatment, or rehabilitation
of patients with PAD and that this unified expertise was
invaluable in the creation of a national PAD education
program. A summary of both prior and ongoing PAD-
directed public screening and awareness programs is sum-
marized in Table I. However, despite more than two de-
cades of societal efforts in promoting public PAD
awareness, most Americans remain unaware of the preva-
lence and risk of PAD. Thus, it is evident that in the absence
of a unified national public awareness campaign, a broad
segment of the population at risk will not hear the message,
may hear disparate messages, or may become inured to
messages whose efficacy is low.
Meeting objectives. This meeting was, therefore, de-
signed to provide both a framework and tools for imple-
mentation of a public awareness campaign by the VDF, its
members, as well as other collaborating organizations. The
overarching goal was to define the next steps required to
develop unified PAD-specific health messages. The specific
meeting objectives included (1) creation of a set of science-
based PAD messages, (2) provision of support to the vas-
cular disease professional community representatives to
develop a campaign to improve public awareness of PAD,
(3) provision of a “hands on” workshop for meeting par-
ticipants to demonstrate key tasks that underlie creation of
a successful national awareness campaign, and (4) provision
of an opportunity for the participants to develop a struc-
tural framework to continue future creation of a vascular
disease public awareness campaign.
PAD messages and themes. To accomplish these
tasks, the staff of the NHLBI was joined by the Ogilvy
Public Relations Worldwide firm and moderated discussion
by a panel of patients who helped define the perceived
needs of those “at risk” and those with clinical PAD. The
meeting participants, as individuals and in small groups,
used these themes to create a common set of messages that
would form the core of the public awareness campaign.
These messages included the high prevalence of PAD and
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its relationship to advancing age and atherosclerosis risk
factors; the systemic nature of atherosclerosis and link
between PAD and cardiovascular ischemic events (myocar-
dial infarction, stroke, and death); the effect of PAD on
quality of life, functional impairment, and limb loss; the
ease of PAD diagnosis by use of the ankle-brachial index
and other diagnostic methods; and the ability of many
lifestyle, pharmacologic, endovascular, and surgical inter-
ventions to improve quality of life, decrease cardiovascular
risk, and diminish the effect of critical limb ischemia and
rates of amputation. The meeting participants developed a
consensus that the lack of recognition of PAD by both
patients and healthcare providers now results in delays in
diagnosis and treatment, sustained high rates of heart attack
and stroke, significant functional disabilities, limb loss, and
death. A summary of these themes is presented in Table II
and is outlined in more detail in the meeting summary
NHLBI Workshop on PAD: Developing a Public Aware-
ness Campaign. 37
NEXT STEPS ON A COMMON ROAD—A
PROPOSAL TO CREATE A NATIONAL PAD
PUBLIC AWARENESS CAMPAIGN
The unified goal of this meeting was to outline the
rationale and steps required for creation of a national PAD
public awareness campaign. The creation of a unified na-
tional action plan to improve national PAD awareness
requires a common “guidebook”. A meeting summary of
the NHLBI Workshop on PAD: Developing a Public
Awareness Campaign outlines core components of such a
campaign as discussed by participants at the January 2003
meeting.37 These core components include potential key
PAD educational messages and methods to promote dis-
semination of these messages to all Americans at risk of or
who have PAD. This summary includes the workshop
presentations and the associated discussions, with a frame-
work for creation of a national PAD educational program.
From this outline, the Vascular Disease Foundation will
continue its role in maintaining a broad, inclusive coalition
of professional societies and public health organizations to
develop a statement of work to be accomplished, to seek
funding, and to create the national action plan.
SUMMARY
The PAD Public Education Strategy Meeting achieved
a central goal that is common to our individual missions. As
individual practitioners and as vascular professional societ-
ies, each of us has demonstrated a commitment to promo-
tion of vascular health. Yet, what we have accomplished to
date as individuals has not yet led to the effect we know we
must achieve. Thus, in 2003, we have now achieved con-
sensus that we share responsibility for development and
dissemination of accurate, unified messages to promote
PAD awareness and improved PAD care to all Americans at
risk. We share a consensus that such messages, when com-
monly created and offered to the public, are most likely to
achieve the rewards in better health that all Americans
deserve.
This coalition has the capacity and intent to work as a
partner of the NHLBI to develop, sponsor, and dissemi-
nate these messages. The Vascular Disease Foundation, a
not-for-profit foundation whose mission includes public
education about the prevention, diagnosis, treatment, and
rehabilitation of PAD, will devote its resources to structure
this process and to create a national PAD awareness cam-
paign. During 2003 and 2004, the coalition will create the
organizational underpinnings and time line for what will
undoubtedly be a multiyear effort. If we are successful in
Table II. Rationale for creation of a national public PAD
educational initiative: Science-based data underlie
effective PAD public health messages
General PAD
message Specific PAD data
Prevalence is high 8–10 million Americans have
PAD
Adverse outcomes
are known
Myocardial
infarction and
stroke
Increased 3 to 5-fold in
individuals with PAD
High excess
mortality
Increased 2- to 3-fold in
individuals with PAD
Amputation Primary cause of amputation
in United States
Quality of life
effect
Severe decrement in
functional capacity; global
decrease in quality of life
Patient awareness
of PAD is low
Less than half of individuals
with PAD are aware of their
diagnosis
Physician awareness
of PAD is low
PAD diagnosis is documented
by less than one third of
primary physicians
PAD is easily
detected
ABI is a cost-effective PAD
diagnostic method proven
useful in office-based care,
in the vascular laboratory,
and at screening sites
Treatment efficacy
is proven
Cardiovascular
ischemic event
reduction
Tobacco cessation, lipid
normalization,
antihypertensive treatment,
glycemic control, smoking
cessation, and use of
antiplatelet medications
Quality of life
can be
improved
Exercise, claudication
medications; percutaneous
and surgical therapies
Amputation can
be averted
Tobacco cessation,
percutaneous, and surgical
therapies
Treatments are
underused
Supervised exercise; smoking
cessation, lipid-lowering,
antihypertensive, and
antiplatelet therapies;
treatment
(revascularization) of
critical limb ischemia is
often delayed
PAD, Peripheral arterial disease; ABI, ankle-brachial index.
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this first national PAD educational endeavor, then we
surely will have created a template to continue for decades
ahead, as we strive to accomplish our broader mandate to
optimally improve global vascular health.
APPENDIX 3. KEY WEB-BASED RESOURCES
Vascular Disease Foundation: http://www.vdf.org/
American Vascular Association: http://www.vascular
web.org/
American Heart Association: http://www.american
heart.org/
Healthy People 2010: http://www.healthypeople.gov/
Heart Truth campaign: http://www.nhlbi.nih.gov/
health/hearttruth/index.htm
Legs for Life program: http://www.legsforlife.org/
National Coalition of Women for Heart Disease:
http://www.womenheart.org/
National Heart, Lung, and Blood Institute: http://
www.nhlbi.nih.gov/
We acknowledge the past support and guidance pro-
vided by the late Dr. David M. Robinson, Deputy Director,
Division of Heart and Vascular Diseases, whose commit-
ment to vascular research, clinical care, and education was a
model and inspiration for this and many other strategic
vascular initiatives.
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